Addex Therapeutics Ltd (NASDAQ:ADXN)
| 0.3525 Delayed Data As of 3:15pm ET |  -0.0132 / -3.61%Today’s Change | 0.34 Today|||52-Week Range 2.28 | -44.06% Year-to-Date |
Latest ADXN News | Press Releases
No recent news for Addex Therapeutics Ltd.
Today’s Trading
| Previous close | 0.37 |
| Today’s open | 0.37 |
| Day’s range | 0.35 - 0.37 |
| Volume | 220 |
| Average volume (3 months) | 64,894 |
| Market cap | $15.1M |
Data as of 3:15pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | +2.04% |
| Earnings growth (this year) | +63.40% |
| Earnings growth (next 5 years) | -23.50% |
| Revenue growth (last year) | -52.87% |
| P/E ratio | NM |
| Price/Sales | 3.14 |
| Price/Book | 1.78 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$21.8M |
| Net profit margin | -1,439.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
